Back to search

Article

A Novel Radio-Genomics Biomarker for Precision Epidermal Growth Factor Receptor Mutation Targeting Therapy in Non-Small Cell Lung Cancer

2025-05-07

Abstract excerpt

<title>Abstract</title> <p> <bold>Background:</bold> Newer generation tyrosine kinase inhibitors (TKI) are becoming more effective against cancers exhibiting certain driver mutations⁠, with those relating to epidermal growth factor receptor (EGFR) being the mostly commonly targeted in non-small cell lung cancer (NSCLC). Treatment decision is currently guided by tissue sampling and genetic testing⁠, an invasive...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a0034b88-63d0-50f6-b8e2-94bb67e89324
DOI
10.21203/rs.3.rs-6396507/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A Novel Radio-Genomics Biomarker for Precision Epidermal Growth Factor Receptor Mutation Targeting Therapy in Non-Small Cell Lung CancerDOI 10.21203/rs.3.rs-6396507/v1
Select a neighboring publication to make it the new centre.